Robert Paul Myers
Chief Medical Officer · Mirum Pharmaceuticals, Inc.
Individual
- 2026
- Oct 14, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Paul Myers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Peetz - $16.29M in MIRM purchases and sales in the last 12 months
- Patrick J. Heron - $9.00M in MIRM purchases and sales in the last 12 months
- Michael G. Grey - $7.20M in MIRM purchases and sales in the last 12 months
- Jolanda Howe - $5.55M in MIRM purchases and sales in the last 12 months
- Eric Bjerkholt - $3.56M in MIRM purchases and sales in the last 12 months
- Peter Radovich - $2.32M in MIRM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Paul Myers?
Robert Paul Myers is a corporate insider, tracked as Chief Medical Officer of Mirum Pharmaceuticals, Inc. (MIRM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert Paul Myers submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.